Markets Expand for Single-Use Bioreactors
Biobags Offer Advantages Over Fixed-Tank Systems
The Challenges of Harmonizing Biomarker Data
Why Trial Success Depends on It
Top 10 Wall Street Losers of 2016
These Companies Lost the Most in a Down Year for Biopharma Stocks
Reading miRNAs for Clinical Meaning
For full access to this article login to GEN Select now.
Toxicogenomics Enhances Drug Discovery
Working Toward Improving Hazard Identification and Risk Assessment
- Adverse health effects resulting from drug toxicity reactions are invariably associated with alterations in gene expression. Toxicogenomics aims at interrogating such changes with the hope of better hazard identification and risk assessment. Microarray technologies continue to lead the pack in toxicogenomics technologies. They, along with other strategies, are ...
Not registered yet? Please fill out the form below and enjoy complimentary access to this and an exclusive collection of premium content and personalization features as a GEN Select insider. Learn More.
Get GEN Select Access Now
- Do not put any letters or characters here if you are not a spy program.